FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

427322009: Glibenclamide micronized (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2673408010 Glyburide micronized en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2673409019 Glibenclamide micronised en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3481616017 Glibenclamide micronized (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3481617014 Glibenclamide micronized en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Glibenclamide micronised Is a Glibenclamide (substance) false Inferred relationship Some
Glibenclamide micronised Is a Sulfonylurea (substance) false Inferred relationship Some
Glibenclamide micronised This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Glibenclamide (substance) true Inferred relationship Some
Glibenclamide micronised Is a Sulphonyluric hypoglycaemic true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely glibenclamide micronized 6 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glibenclamide micronised Inferred relationship Some
Glibenclamide micronised 3 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glibenclamide micronised Inferred relationship Some
Glibenclamide micronised 1.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glibenclamide micronised Inferred relationship Some
Glibenclamide micronised 4.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glibenclamide micronised Inferred relationship Some
Glibenclamide micronised 3 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glibenclamide micronised Inferred relationship Some 1
Glibenclamide micronised 3 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Glibenclamide micronised Inferred relationship Some 1
Product containing precisely glibenclamide micronized 6 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glibenclamide micronised Inferred relationship Some 1
Product containing precisely glibenclamide micronized 6 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Glibenclamide micronised Inferred relationship Some 1
Glibenclamide micronised 1.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glibenclamide micronised Inferred relationship Some 1
Glibenclamide micronised 1.5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Glibenclamide micronised Inferred relationship Some 1
Glibenclamide micronised 4.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glibenclamide micronised Inferred relationship Some 1
Glibenclamide micronised 4.5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Glibenclamide micronised Inferred relationship Some 1
Glibenclamide micronised 3 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Glibenclamide micronised Inferred relationship Some 1
Glibenclamide micronised 1.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Glibenclamide micronised Inferred relationship Some 1
Product containing precisely glibenclamide micronized 6 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Glibenclamide micronised Inferred relationship Some 1
Glibenclamide micronised 4.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Glibenclamide micronised Inferred relationship Some 1

This concept is not in any reference sets

Back to Start